Abstract
The in vitro activity of vancomycin and combinations of vancomycin-gentamicin and vancomycin-streptomycin against enterococci was investigated. The minimal inhibitory concentration of vancomycin for 99 of 100 enterococcal strains isolated clinically was 3.12 μg or less/ml. When cultures of eight strains were incubated with vancomycin, regardless of the inoculum size (106, 105, or 104) and concentration of vancomycin (10 or 20 μg/ml), there was no significant reduction in the number of viable enterococci at 6, 24, and 48 h. Gentamicin and streptomycin in concentrations attainable clinically were not effective against enterococci. Vancomycin combined with gentamicin or streptomycin was tested against 41 enterococcal strains. With the combination of vancomycin at 10 μg/ml and gentamicin at 4 μg/ml or vancomycin at 5 μg/ml and gentamicin at 4 μg/ml, synergism was demonstrated against all 41 strains at 6 h. The combination of vancomycin at 10 μg/ml and streptomycin at 10 μg/ml was only synergistic against 25 of 41 strains at 6 h, and only 22 of 41 strains were affected synergistically at 6 h by vancomycin at 5 μg/ml with streptomycin at 10 μg/ml. With few exceptions, the enhanced killing was more pronounced at 24 and 48 h. The combination of vancomycin and gentamicin or vancomycin and streptomycin (where in vitro studies demonstrate synergism) may be a useful alternate therapy in enterococcal endocarditis.
Full text
PDF![120](https://cdn.ncbi.nlm.nih.gov/pmc/blobs/590c/444516/e1ff01d5c138/aac00350-0048.png)
![121](https://cdn.ncbi.nlm.nih.gov/pmc/blobs/590c/444516/297e90737a8f/aac00350-0049.png)
![122](https://cdn.ncbi.nlm.nih.gov/pmc/blobs/590c/444516/305eaaac6708/aac00350-0050.png)
![123](https://cdn.ncbi.nlm.nih.gov/pmc/blobs/590c/444516/129eb0b0f2a0/aac00350-0051.png)
![124](https://cdn.ncbi.nlm.nih.gov/pmc/blobs/590c/444516/47e4a8f7f24c/aac00350-0052.png)
Selected References
These references are in PubMed. This may not be the complete list of references from this article.
- Facklam R. R., Moody M. D. Presumptive identification of group D streptococci: the bile-esculin test. Appl Microbiol. 1970 Aug;20(2):245–250. doi: 10.1128/am.20.2.245-250.1970. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Fekety F. R., Jr, Weiss P. Antibiotic synergism: enhanced susceptibility of enterococci to combinations of streptomycin and penicillins or cephalosporins. Antimicrob Agents Chemother (Bethesda) 1966;6:156–164. doi: 10.1128/AAC.6.2.156. [DOI] [PubMed] [Google Scholar]
- Friedberg C. K., Rosen K. M., Bienstock P. A. Vancomycin therapy for enterococcal and Streptococcus viridans endocarditis. Successful treatment of six patients. Arch Intern Med. 1968 Aug;122(2):134–140. [PubMed] [Google Scholar]
- Green G. R., Peters G. A., Gerach J. E. Treatment of bacterial endocarditis in patients with penicillin hypersensitivity. Ann Intern Med. 1967 Aug;67(2):235–249. doi: 10.7326/0003-4819-67-2-235. [DOI] [PubMed] [Google Scholar]
- Isenberg H. D., Goldberg D., Sampson J. Laboratory studies with a selective Enterococcus medium. Appl Microbiol. 1970 Sep;20(3):433–436. doi: 10.1128/am.20.3.433-436.1970. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Jawetz E., Sonne M. Penicillin-streptomycin treatment of enterococcal endocarditis. A re-evaluation. N Engl J Med. 1966 Mar 31;274(13):710–715. doi: 10.1056/NEJM196603312741304. [DOI] [PubMed] [Google Scholar]
- Jawetz E. The use of combinations of antimicrobial drugs. Annu Rev Pharmacol. 1968;8:151–170. doi: 10.1146/annurev.pa.08.040168.001055. [DOI] [PubMed] [Google Scholar]
- KIRBY W. M., DIVELBISS C. L. Vancomycin; clinical and laboratory studies. Antibiot Annu. 1956:107–117. [PubMed] [Google Scholar]
- Lerner P. I., Weinstein L. Infective endocarditis in the antibiotic era. N Engl J Med. 1966 Jan 27;274(4):199–contd. doi: 10.1056/NEJM196601272740407. [DOI] [PubMed] [Google Scholar]
- Mandell G. L., Kaye D., Levison M. E., Hook E. W. Enterococcal endocarditis. An analysis of 38 patients observed at the New York Hospital-Cornell Medical Center. Arch Intern Med. 1970 Feb;125(2):258–264. doi: 10.1001/archinte.125.2.258. [DOI] [PubMed] [Google Scholar]
- Mandell G. L., Lindsey E., Hook E. W. Synergism of vancomycin and streptomycin for enterococci. Am J Med Sci. 1970 May;259(5):346–349. doi: 10.1097/00000441-197005000-00006. [DOI] [PubMed] [Google Scholar]
- Moellering R. C., Jr, Wennersten C., Weinberg A. N. Synergy of penicillin and gentamicin against Enterococci. J Infect Dis. 1971 Dec;124 (Suppl):S207–S209. doi: 10.1093/infdis/124.supplement_1.s207. [DOI] [PubMed] [Google Scholar]
- Phair J. P., Watanakunakorn C., Bannister T. In vitro susceptibility of Pseudomonas aeruginosa to carbenicillin and the combination of carbenicillin and gentamicin. Appl Microbiol. 1969 Sep;18(3):303–306. doi: 10.1128/am.18.3.303-306.1969. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Rahal J. J., Jr, Meyers B. R., Weinstein L. Treatment of bacterial endocarditis with cephalothin. N Engl J Med. 1968 Dec 12;279(24):1305–1309. doi: 10.1056/NEJM196812122792403. [DOI] [PubMed] [Google Scholar]
- Toala P., McDonald A., Wilcox C., Finland M. Susceptibility of group D streptococcus (enterococcus) to 21 antibiotics in vitro, with special reference to species differences. Am J Med Sci. 1969 Dec;258(6):416–430. doi: 10.1097/00000441-196912000-00006. [DOI] [PubMed] [Google Scholar]
- Watanakunakorn C. Penicillin combined with gentamicin or streptomycin: synergism against enterococci. J Infect Dis. 1971 Dec;124(6):581–586. doi: 10.1093/infdis/124.6.581. [DOI] [PubMed] [Google Scholar]
- Westenfelder G. O., Paterson P. Y., Reisberg B. E., Carlson G. M. Vancomycin-streptomycin synergism in enterococcal endocarditis. JAMA. 1973 Jan 1;223(1):37–40. [PubMed] [Google Scholar]
- Wilkowske C. J., Facklam R. R., Washington J. A., 2nd, Geraci J. E. Antibiotics synergism: enhanced susceptibility of group D streptococci to certain antibiotic combinations. Antimicrob Agents Chemother (Bethesda) 1970;10:195–200. [PubMed] [Google Scholar]